Big Data Analyses for Continuous Evaluation of Pharmacotherapy: A Proof of Principle with Doxapram in Preterm Infants

Robert Flint; Willem Weteringen; S Voller; Jarinda Poppe; Birgit Koch; Ronald Groot; Dick Tibboel; Catherijne Knibbe; Irwin Reiss; SHP (Sinno) Simons

doi:10.2174/1381612823666170918121556

Big Data Analyses for Continuous Evaluation of Pharmacotherapy: A Proof of Principle with Doxapram in Preterm Infants

Robert Flint, Willem Weteringen, S Voller, Jarinda Poppe, Birgit Koch, Ronald Groot, Dick Tibboel, Catherijne Knibbe, Irwin Reiss, SHP (Sinno) Simons

Research output: Contribution to journal › Article › Academic › peer-review

11 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	5919-5927
Number of pages	9
Journal	Current Pharmaceutical Design
Volume	23
Issue number	38
DOIs	https://doi.org/10.2174/1381612823666170918121556
Publication status	Published - 2017

Research programs

EMC MM-03-54-04-A

Access to Document

10.2174/1381612823666170918121556

http://hdl.handle.net/1765/105196

Cite this

@article{b8ca69dcf09b4d9ebfc19454ddfbd417,

title = "Big Data Analyses for Continuous Evaluation of Pharmacotherapy: A Proof of Principle with Doxapram in Preterm Infants",

author = "Robert Flint and Willem Weteringen and S Voller and Jarinda Poppe and Birgit Koch and Ronald Groot and Dick Tibboel and Catherijne Knibbe and Irwin Reiss and Simons, {SHP (Sinno)}",

year = "2017",

doi = "10.2174/1381612823666170918121556",

language = "Undefined/Unknown",

volume = "23",

pages = "5919--5927",

journal = "Current Pharmaceutical Design",

issn = "1381-6128",

publisher = "Bentham Science Publishers",

number = "38",

}

TY - JOUR

T1 - Big Data Analyses for Continuous Evaluation of Pharmacotherapy: A Proof of Principle with Doxapram in Preterm Infants

AU - Flint, Robert

AU - Weteringen, Willem

AU - Voller, S

AU - Poppe, Jarinda

AU - Koch, Birgit

AU - Groot, Ronald

AU - Tibboel, Dick

AU - Knibbe, Catherijne

AU - Reiss, Irwin

AU - Simons, SHP (Sinno)

PY - 2017

Y1 - 2017

U2 - 10.2174/1381612823666170918121556

DO - 10.2174/1381612823666170918121556

M3 - Article

C2 - 28925893

SN - 1381-6128

VL - 23

SP - 5919

EP - 5927

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

IS - 38

ER -